| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| pyridostigmine | acetylcholinesterase | small molecule | Successful target | TTD , drugbank , DGIDB | Myasthenia Gravis[MeSHID:D009157] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.22 | approved,investigational | inhibitor |
| pyridostigmine | acetylcholinesterase | small molecule | Successful target | TTD , drugbank , DGIDB | Myasthenia Gravis[MeSHID:D009157] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
2.22 | approved,investigational | inhibitor |
| pyridostigmine | cholinesterase | small molecule | NA | drugbank , DGIDB | Myasthenia Gravis[MeSHID:D009157] Disease[MeSHID:D004194] Coronavirus Infections[MeSHID:D018352] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.73 | approved,investigational | inhibitor |
| pyridostigmine | cholinesterase | small molecule | NA | drugbank , DGIDB | Myasthenia Gravis[MeSHID:D009157] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.73 | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||